Canada markets closed

Organigram Holdings Inc. (OGI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3400+0.0600 (+4.69%)
At close: 04:00PM EST
1.3110 -0.03 (-2.16%)
After hours: 07:44PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.2800
Bid1.2800 x 3000
Ask1.3500 x 900
Day's Range1.2750 - 1.3500
52 Week Range0.9700 - 5.0800
Avg. Volume1,238,224
Market Cap110.024M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-1.8500
Earnings DateJan 10, 2024 - Jan 15, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.80
  • Business Wire

    Organigram Increases Investment in Phylos After Successful Milestone Achievement

    TORONTO, November 28, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that Phylos Bioscience Inc. ("Phylos"), a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023 (the "Loan Agreement") and has closed the second tranche under the Loan Agreement with Organigram advancing US$2.75 million to Phylos.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector • Organigram received C$124.6 million investment from BAT; the company also announced the appointment of an interim CFO. • Trulieve posts robust Q3 2023 financial results, showcasing strong financial performance, debt reduction, and strategic growth initiatives. • Canopy Growth reported narrowed Q2 losses, indicating a positive shift amid restructuring efforts. • […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclus

  • Business Wire

    Organigram Announces Interim Chief Financial Officer

    TORONTO, November 10, 2023--The Board of Directors (the "Board") of Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer ("CFO") in order to take time to focus on his health and recovery following surgery later this month.